Effective treatment of stage I uterine papillary serous carcinoma with high dose-rate vaginal apex radiation (192Ir) and chemotherapy.

Turner, B C; Knisely, J P; Kacinski, B M; Haffty, B G; Gumbs, A A; Roberts, K B; Frank, A H; Peschel, R E; Rutherford, T J; Edraki, B; Kohorn, E I; Chambers, S K; Schwartz, P E; Wilson, L D

Turner, B C; Knisely, J P; Kacinski, B M; Haffty, B G; Gumbs, A A; Roberts, K B; Frank, A H; Peschel, R E; Rutherford, T J; Edraki, B; Kohorn, E I; Chambers, S K; Schwartz, P E; Wilson, L D.

Affiliation

Turner BC; Department of Therapeutic Radiology, Yale University School of Medicine, New Haven, CT 06520, USA.

Int J Radiat Oncol Biol Phys ; 40(1): 77-84, 1998 Jan 01.

Article in En | MEDLINE | ID: mdl-9422561

Subject(s)

Antineoplastic Combined Chemotherapy Protocols/therapeutic use; Cystadenocarcinoma, Papillary/drug therapy; Cystadenocarcinoma, Papillary/radiotherapy; Uterine Neoplasms/drug therapy; Uterine Neoplasms/radiotherapy; Adult; Aged; Aged, 80 and over; Brachytherapy; Chemotherapy, Adjuvant; Cystadenocarcinoma, Papillary/pathology; Disease-Free Survival; Female; Humans; Hysterectomy; Middle Aged; Neoplasm Recurrence, Local/drug therapy; Neoplasm Recurrence, Local/radiotherapy; Neoplasm Staging; Retrospective Studies; Salvage Therapy; Uterine Neoplasms/pathology

Search on Google

XML

PubMed Links

Database: MEDLINE Main subject: Uterine Neoplasms / Antineoplastic Combined Chemotherapy Protocols / Cystadenocarcinoma, Papillary Type of study: Observational_studies / Risk_factors_studies Limits: Adult / Aged / Aged80 / Female / Humans / Middle aged Language: En Year: 1998 Type: Article

Search on Google

XML

PubMed Links